ALDH1 and SALL4 Expression in Cell Block Samples from Patients with Lung Adenocarcinoma and Malignant Pleural Effusion

被引:11
|
作者
Kanayama, Tomohiro [1 ,2 ]
Taniguchi, Toshiaki [1 ]
Tomita, Hiroyuki [1 ]
Niwa, Ayumi [1 ]
Noguchi, Kei [2 ]
Matsuo, Mikiko [1 ]
Imaizumi, Yuko [1 ]
Kuroda, Takahiro [1 ]
Hatano, Yuichiro [1 ]
Okazaki, Isao [3 ]
Kato, Tatsuo [4 ]
Hara, Akira [1 ,2 ]
机构
[1] Gifu Univ, Dept Tumor Pathol, Grad Sch Med, 1-1 Yanagido, Gifu 5011194, Japan
[2] Gifu Univ Hosp, Div Pathol, 1-1 Yanagido, Gifu 5011194, Japan
[3] Natl Hosp Org Nagara Med Ctr, Dept Clin Lab, Gifu 5028558, Japan
[4] Natl Hosp Org Nagara Med Ctr, Dept Resp Med, Gifu 5028558, Japan
关键词
malignant pleural effusion; cancer stem cell; cell block; ALDH1; SALL4; CANCER STEM-CELLS; DYNAMICS; NETWORK; MARKER;
D O I
10.3390/diagnostics11081463
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Malignant pleural effusion (MPE) can accompany advanced lung adenocarcinoma. Recent studies suggest that MPE could contain a heterogeneous subpopulation of cells with stem-like properties, such as tumorigenicity and self-renewal, indicating that they could be the source of metastasis. Although previous studies analyzed the correlation between cancer stem cell (CSC) marker expression and clinical outcomes using lung cancer tissues, investigations regarding the association of MPE with CSC marker expression are limited. We performed immunohistochemistry to examine the expression of aldehyde dehydrogenase 1 (ALDH1) and Sal-like 4 (SALL4) in 46 cell block samples of MPE from patients with lung adenocarcinoma. ALDH1-positive and SALL4-positive cancer cells in MPE were detected in 30 (65.2%) and 21 samples (45.7%), respectively. Cluster formation was detected in 26 samples (56.5%). The number of clusters was significantly higher in ALDH1-positive/SALL4-negative samples. SALL4 expression was inversely correlated with the cluster ratio (r = -0.356) and positively associated with the Ki-67 index (r = 0.326), suggesting that MPE cells with high SALL4 expression comprised the proliferative subpopulation. In conclusion, we demonstrated that MPE contains an ALDH1-positive/SALL4-negative subpopulation exhibiting cluster formation and a SALL4-positive proliferative subpopulation.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] PD-L1 Expression of Tumor Cells, Macrophages, and Immune Cells in Non-Small Cell Lung Cancer Patients with Malignant Pleural Effusion
    Tseng, Yen-Han
    Ho, Hsiang-Ling
    Lai, Chiung-Ru
    Luo, Yung-Hung
    Tseng, Yen-Chiang
    Whang-Peng, Jacqueline
    Lin, Yi-Hsuan
    Chou, Teh-Ying
    Chen, Yuh-Min
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (03) : 447 - 453
  • [22] ALDH1-High Ovarian Cancer Stem-Like Cells Can Be Isolated from Serous and Clear Cell Adenocarcinoma Cells, and ALDH1 High Expression Is Associated with Poor Prognosis
    Kuroda, Takafumi
    Hirohashi, Yoshihiko
    Torigoe, Toshihiko
    Yasuda, Kazuyo
    Takahashi, Akari
    Asanuma, Hiroko
    Morita, Rena
    Mariya, Tasuku
    Asano, Takuya
    Mizuuchi, Masahito
    Saito, Tsuyoshi
    Sato, Noriyuki
    PLOS ONE, 2013, 8 (06):
  • [23] Detecting EGFR mutations and ALK/ROS1 rearrangements in non-small cell lung cancer using malignant pleural effusion samples
    Yao, Yi
    Peng, Min
    Shen, Qinglin
    Hu, Qinyong
    Gong, Hongyun
    Li, Qingqing
    Zheng, Zhongliang
    Xu, Bin
    Li, Yingge
    Dong, Yi
    THORACIC CANCER, 2019, 10 (02) : 193 - 202
  • [24] Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusion
    Hao Zeng
    Yuanyuan Zhang
    Sihan Tan
    Qin Huang
    Xin Pu
    Panwen Tian
    Yalun Li
    BMC Pulmonary Medicine, 24
  • [25] Does the Amount of Malignant Pleural Effusion Affect the Survival in Patients with Non-Small Cell Lung Cancer?
    Nakamura, Shota
    Okasaka, Toshiki
    Kawaguchi, Koji
    Fukui, Takayuki
    Fukumoto, Koichi
    Yokoi, Kohei
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S727 - S727
  • [26] Prognostic Impact of Malignant Pleural Effusion at Presentation in Patients with Metastatic Non-Small-Cell Lung Cancer
    Morgensztern, Daniel
    Waqar, Saiama
    Subramanian, Janakiraman
    Trinkaus, Kathryn
    Govindan, Ramaswamy
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (10) : 1485 - 1489
  • [27] Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusion
    Zeng, Hao
    Zhang, Yuanyuan
    Tan, Sihan
    Huang, Qin
    Pu, Xin
    Tian, Panwen
    Li, Yalun
    BMC PULMONARY MEDICINE, 2024, 24 (01)
  • [28] Evaluation of DNA/RNA quality from cell block of malignant mesothelioma and lung adenocarcinoma
    Tatsumi, Shigenobu
    Takeuchi, Mao
    Fujii, Tomomi
    Sugimoto, Aya
    Sekita-Hatakeyama, Yoko
    Nishikawa, Takeshi
    Uchiyama, Tomoko
    Morita, Kohei
    Itami, Hiroe
    Takeda, Maiko
    Yamazaki, Masaharu
    Ohbayashi, Chiho
    DIAGNOSTIC CYTOPATHOLOGY, 2022, 50 (06) : 273 - 283
  • [29] Malignant pleural effusion as a predictor of the efficacy of anti-PD-1 antibody in patients with non-small cell lung cancer
    Shibaki, Ryota
    Murakami, Shuji
    Shinno, Yuki
    Matsumoto, Yuji
    Goto, Yasushi
    Kanda, Shintaro
    Horinouchi, Hidehito
    Fujiwara, Yutaka
    Motoi, Noriko
    Yamamoto, Noboru
    Ohe, Yuichiro
    THORACIC CANCER, 2019, 10 (04) : 815 - 822
  • [30] The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non-small cell lung cancer
    Chen, Yao
    Mathy, Nicholas W.
    Lu, Hongda
    MOLECULAR MEDICINE REPORTS, 2018, 17 (06) : 8019 - 8030